Jun Yan, Pharm.D., has been a medical writer since 2005 and has written extensively for pharmaceutical and biotech companies in a wide range of therapeutic areas. Her contributions included study reports and clinical summaries in new drug applications and biologic licensing applications that were eventually approved by regulatory agencies.
In addition, Jun has written and published more than 300 news articles in Psychiatric News and served as a manuscript editor at American Journal of Health-System Pharmacy for 5 years.
Jun has provided services for over a dozen companies and organizations, including the following:
Johnson and Johnson
MedImmune (now AstraZeneca)
Food and Drug Administration (CDER)
MannKind Corp
Analysis Group Consulting
Provention Bio, Inc.
Covance
Parexel
Amgen
Precision Biosciences
Prometic BioTherapeutics
Celimmune, Inc.
Grifols
American Psychiatric Association
MedImmune (now AstraZeneca)
Food and Drug Administration (CDER)
MannKind Corp
Analysis Group Consulting
Provention Bio, Inc.
Covance
Parexel
Amgen
Precision Biosciences
Prometic BioTherapeutics
Celimmune, Inc.
Grifols
American Psychiatric Association